Mujahid A. Rizvi

The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway

Christiane Querfeld, Mujahid A. Rizvi, Timothy M. Kuzel et al. · Journal of Investigative Dermatology · 2006 · 89 citations · Full text

Medicine, Oncology, Pharmacology +9

Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines

Mujahid A. Rizvi, Kulsoom Ghias, Katharine M. Davies et al. · Molecular Cancer Therapeutics · 2006 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

A call to action to advance patient‐focused and decentralized clinical trials

R. Donald Harvey, Therica M. Miller, Patricia A. Hurley et al. · Cancer · 2024 · 24 citations · Full text

Medicine, Oncology, Translational Sciences +11

Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy

Sara K. Vesely, Jedidiah J. Perdue, Mujahid A. Rizvi et al. · Annals of Internal Medicine · 2004 · 18 citations

Medicine, Hematology, Surgery +7

Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement

Ramya Thota, Patricia A. Hurley, Therica M. Miller et al. · Journal of Clinical Oncology · 2024 · 15 citations · Full text

Medicine, Oncology, Clinical Research Regulation +16